News • 5-10-2011

Early recognition and treatment of TIA

TIA was defined in 2002 as “a brief episode of neurologic dysfunction cause by focal brain or retinal ischaemia with clinical symptoms lasting less than one hour”. However, this has recently been updated to include the phrase “and without evidence of acute infarction”

Read more
Webcast •

Early recognition and treatment of TIA

Prof. Pierre Amarenco discusses the importance of early recognition and treatment of TIAs to ensure a better prognosis.

Watch

The EURIKA Study

3-10-2011
The objective of this study was to estimate the excess risk attributable, firstly, to the presence of CVD risk factors and, secondly, to the lack of control of these risk factors in primary prevention care across Europe. BMC Public Health. 2011 Sep 18
Read more
Webcast •

Lifetime CV risk

Prof. Deanfield and prof. Hobbs discuss the shift in focus from treating patients with clinical problems arising from established CV disease to CV prevention in patients with risk factors for developing CV disease. Watch
News • 15-9-2011

New NICE guidelines for hypertension

The recent updated guidance from the National Institute for Health and Clinical Excellence (NICE) on the management of hypertension in adults will have far reaching implications for day to day practice in the United Kingdom. Read more
News • 22-8-2011

Abstracts EPCCS 2011

View the abstracts accepted for oral and poster presentations for the 4th Annual scientific meeting of the EPCCS

Read more
Webcast •

Update on hypertension

Prof. Richard McManus discusses the shift in diagnosis of hypertension from clinic measurement to ambulatory and home measurement. Watch
Webcast •

Hobbs' overview of EPCCS 2011

Prof. Richard Hobbs gives an overview of highlights from EPCCS 2011, with a summary of sessions that were held, e.g. concerning lifetime cardiovascular risk, hypertension, diabetes, and chronic kidney disease. Watch

Meta-analysis: CV effects of intensive glucose lowering

3-10-2011
Glucose lowering treatments are widely used to treat type 2 diabetes ant to prevent long term cardiovascular complications as well as impairment of renal and visual functions. This meta-analysis aimed to determine the benefit of such treatment on clinical end points. BMJ. 2011 Jul 26;343:d4169. doi: 10.1136/bmj.d4169
Read more
News • 19-9-2011

EPCCS 2011 Highlights

Čtvrtý výroční kongres EPCCS, Berlin 2011 Read more

The role of the primary care physician in managing early stages of chronic kidney disease

13-9-2011
Recent increases in obesity, diabetes, and hypertension, along with the aging of the population, are driving a dramatic rise in the prevalence of chronic kidney disease (CKD). Primary care practices are at the forefront of detection and management of early CKD. Read more

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence

19-8-2011
One in 20 ischemic strokes occurs soon after withdrawal of antithrombotic agents, warn researchers. Read more

Upcoming meetings

Meeting reports & resources

EPCCS 2017 Report of the Cardiovascular Summit held in Dublin, Ireland
EPCCS Guidance Documents Evidence- and meeting-based guidance for primary care
EPCCS 2015 Report of 8th Annual EPCCS meeting held in Prague.
EPCCS 2014 Report of 7th Annual EPCCS meeting held in Brussels.
All meeting reports...